Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/17/2023 | 26.28% | Piper Sandler | → $37 | Initiates Coverage On | → Overweight |
08/09/2023 | 63.82% | JP Morgan | $45 → $48 | Maintains | Overweight |
03/07/2023 | 67.24% | Canaccord Genuity | → $49 | Initiates Coverage On | → Buy |
03/06/2023 | 46.76% | Raymond James | $42 → $43 | Maintains | Outperform |
11/09/2022 | 43.34% | Raymond James | $48 → $42 | Maintains | Outperform |
09/14/2022 | 57% | Argus Research | → $46 | Upgrades | Hold → Buy |
09/06/2022 | 84.3% | Wells Fargo | → $54 | Upgrades | Equal-Weight → Overweight |
05/04/2022 | 63.82% | Raymond James | $55 → $48 | Maintains | Outperform |
11/11/2021 | 87.71% | Raymond James | $59 → $55 | Maintains | Outperform |
10/14/2021 | 101.37% | Raymond James | → $59 | Upgrades | Market Perform → Outperform |
09/30/2021 | 115.02% | Jefferies | $45 → $63 | Upgrades | Hold → Buy |
03/05/2021 | 53.58% | Morgan Stanley | $53 → $45 | Maintains | Equal-Weight |
01/06/2021 | 67.24% | RBC Capital | $59 → $49 | Downgrades | Outperform → Sector Perform |
10/28/2020 | 67.24% | Wells Fargo | $55 → $49 | Maintains | Equal-Weight |
09/17/2020 | 115.02% | SVB Leerink | $64 → $63 | Maintains | Outperform |
06/08/2020 | 115.02% | SVB Leerink | $55 → $63 | Maintains | Outperform |
04/17/2020 | — | Argus Research | Downgrades | Buy → Hold | |
04/02/2020 | 80.89% | Morgan Stanley | $54 → $53 | Maintains | Equal-Weight |
03/24/2020 | 94.54% | JP Morgan | → $57 | Upgrades | Neutral → Overweight |
03/20/2020 | 77.47% | SVB Leerink | $54 → $52 | Upgrades | Market Perform → Outperform |
03/11/2020 | 80.89% | Wells Fargo | $63 → $53 | Maintains | Equal-Weight |
01/21/2020 | 138.91% | Cantor Fitzgerald | $60 → $70 | Maintains | Overweight |
10/11/2019 | — | Argus Research | Upgrades | Hold → Buy | |
09/30/2019 | 77.47% | Wells Fargo | $45 → $52 | Maintains | Market Perform |
09/25/2019 | 87.71% | SunTrust Robinson Humphrey | $51 → $55 | Maintains | Hold |
03/26/2019 | 84.3% | Morgan Stanley | $67 → $54 | Maintains | Equal-Weight |
03/20/2019 | 74.06% | SunTrust Robinson Humphrey | → $51 | Initiates Coverage On | → Hold |
12/21/2018 | 57% | Wells Fargo | $64 → $46 | Maintains | Market Perform |
What is the target price for Perrigo (PRGO)?
The latest price target for Perrigo (NYSE: PRGO) was reported by Piper Sandler on November 17, 2023. The analyst firm set a price target for $37.00 expecting PRGO to rise to within 12 months (a possible 26.28% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Perrigo (PRGO)?
The latest analyst rating for Perrigo (NYSE: PRGO) was provided by Piper Sandler, and Perrigo initiated their overweight rating.
When is the next analyst rating going to be posted or updated for Perrigo (PRGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Perrigo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Perrigo was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating Perrigo (PRGO) correct?
While ratings are subjective and will change, the latest Perrigo (PRGO) rating was a initiated with a price target of $0.00 to $37.00. The current price Perrigo (PRGO) is trading at is $29.30, which is within the analyst's predicted range.